Sequani Medical

Executive Summary

Sequani Medical is a UK-based contract research organization (CRO) specializing in non-clinical safety testing and toxicology services for the pharmaceutical, agrochemical, and chemical industries. Founded in 2015 and headquartered in Ledbury, the company supports clients from lead optimization through regulatory submission, ensuring safety and efficacy of new products. As a private CRO, Sequani benefits from the growing trend of outsourcing non-clinical research, positioning itself as a key partner for drug and chemical development. Its service portfolio and expertise in regulatory compliance enable it to serve a diverse client base, though its modest scale may limit competitive advantage against larger CROs. The company's focus on quality and niche toxicology services could drive steady growth, but visibility remains limited given its private status.

Upcoming Catalysts (preview)

• Q3 2026Expansion of GLP-compliant laboratory facilities70% success
• Q4 2026Strategic partnership with a top-10 pharmaceutical company for toxicology services50% success
• 2027Acquisition by a larger CRO or private equity firm30% success